BioRock Ventures
Venture capitalActively deployingBay Area · Seed–Late Stage · 1 people tracked
Investment thesis
BioRock Ventures targets private life science companies developing best-in-class medicines, with investments spanning from angel and seed through Series A to pre-IPO and M&A stages. The fund is agnostic across disease areas, stages, and therapeutic modalities, supporting therapeutics startups with capital and expertise from seasoned operators with deep pharma and biotech experience.
Source: firm website, verified Jul 21, 2026.
Team · 1 people
from the firm's websiteFounding managing partner of BioRock Ventures with two decades of therapeutics startup operating experience. Previously held leadership roles in M&A negotiations, business evaluation, and strategy at major pharmaceutical companies including Johnson & Johnson and Forest/Allergan/Abbvie. Has served as consulting chief business officer to early-stage ventures globally and began venture investing a decade ago, helping form two companies that each achieved IPO exits valued over $1 billion.
Investments · 4 tracked
founders shown can be your intro pathFrequently asked questions
- What stage does BioRock Ventures invest at?
- BioRock Ventures invests at the Seed, Series A, Late Stage stages.
- What sectors does BioRock Ventures focus on?
- BioRock Ventures focuses on Biotech, Medical Devices.
- Where is BioRock Ventures located?
- BioRock Ventures is headquartered in Bay Area, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
A European investment firm established in 2016 by former Index Ventures life sciences professionals with over 20 years of experience in drug discovery and therapeutic development for unmet medical needs.